D144VRC Entrust Escudo
Implantable Cardioverter Defibrillator (ICD)
D144VRC Entrust Escudo
Information

Device Survival Probability


D144VRC_D154VRC_SURV
    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr at 98 mo  
% Excluding Normal Battery Depletion 100.0 99.9 99.8 99.7 99.5 99.2 98.9 98.9 98.9  
% Including Normal Battery Depletion 99.9 99.6 99.3 98.8 97.8 92.3 84.3 75.5 72.5  
#   13657 12422 11160 9907 8779 7279 5310 722 104  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code VVE-VVIR
Max. Delivered Energy 35 J
More
Connector Style Cx Style
Serial Number Prefix PNT
Mass 68 g
Volume 35 cc
Waveform Biphasic
X-Ray ID PNT
Hide this content
Cx Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 4.8 5.0 5.2 5.3
Quarterly 7.5 8.3 8.8 9.0
Semi-annual 9.0 10.0 10.7 11.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode VVI; Ventricular Lower Pacing Rate 60ppm; Ventricular Pulse Width 0.4ms; Ventricular Pulse Amplitude 3V; Ventricle Impedance 510ohms; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

EOL Indication

EOL device status is defined as three months following an ERI indication assuming the following post-ERI conditions: 100% VVI pacing at 60 min-1, 2.5 V, 0.4 ms; 500 Ohm pacing load; and six full-energy charges. EOL may be indicated before the end of three months if the device exceeds these conditions.

Information

Distribution Data

US Market Release
CE Approval Date2008-06-05
Registered USA Implants
Estimated Active USA Implants
Normal Battery Depletions
US Market Release
CE Approval Date2008-06-05
Estimated WW Distribution5051
Normal Battery Depletions4
Information

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised
Information

Malfunctions (WW)

Therapy Function Not Compromised 3
Electrical Component 1
Possible Early Battery Depletion 2
Therapy Function Compromised 1
Electrical Component 1
Information

Elective Replacement (ERI)

Battery voltage less than or equal to 2.61 V on three consecutive daily automatic measurements.

Information

Charge Time


D144VRC_D154VRC_CHRG

Data as of January 31, 2014

www.medtronic.com/productperformance 301050